Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
EQ 300
Boldenone Undecylenate
- Compound
- Boldenone Undecylenate
- Category
- Injectable Steroids
- Brand
- Equipoise, EQ
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 10 ml
- Strength
- 300 mg/ml
- Route
- Injection
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for EQ 300 are not yet published. They will be added here once testing is complete.
Product information
About EQ 300
300 mg/mL · 10 mL · Zyvex Pharmaceuticals
EQ 300 from Zyvex Pharmaceuticals contains boldenone undecylenate at 300 mg/mL and comes in a 10 mL presentation.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Basic Identification & Composition
Product Name & Active Ingredient
EQ 300 is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is boldenone undecylenate, classified as a anabolic androgenic steroid.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Product name | EQ 300 |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredient | Boldenone Undecylenate |
| Strength | 300 mg/mL |
| Package | 10 mL |
| Drug class | Anabolic androgenic steroid |
| Chemical formula | C30H44O3 |
| Presentation | Injectable preparation; route as verified on the medicinal label |
Dosage Form
An injectable preparation supplied by concentration and pack volume. The vehicle and whether the preparation is a solution or suspension affect handling. Administration must follow the exact medicinal label and appropriate sterile technique; do not infer the route from concentration alone.
Clinical Particulars
EQ 300 uses
EQ 300 from Zyvex Pharmaceuticals contains boldenone undecylenate. Boldenone undecylenate is associated principally with veterinary anabolic use. A routine human treatment or medical wellbeing indication is not established by the available evidence.
People using anabolic steroids take boldenone for muscle and performance goals. Veterinary use does not provide a human dose or show that a preparation is suitable for human injection.
A small observational study reported boldenone exposure of 250–1000 mg per week among users of multiple drugs. This is a reported range, not a representative or safe protocol; the study does not validate an ester-specific schedule or this product.
Dosage and Administration
A reliable routine human dosing regimen cannot be established from the available clinical evidence. The product strength must not be converted into a self-treatment schedule. Human use requires an appropriately supervised clinical or research setting with a defined protocol. A regimen used for an animal preparation or another ester must not be transferred to this injectable product.
Contraindications
A complete human contraindication profile cannot be assumed for this preparation. Avoid use with hypersensitivity, during pregnancy or breastfeeding, or in children. Significant cardiovascular, liver, kidney, prostate or endocrine disease requires specialist assessment. These precautions do not establish suitability in people without those conditions.
Warnings and Precautions
Human evidence for this particular ester and preparation is limited. General androgen risks include gonadal suppression, adverse lipid changes, increased haematocrit and virilisation. Injection also introduces risks from contamination and local injury. Short-term tolerance does not establish long-term safety.
Risks and Interactions
Drug & Food Interactions
Formal human interaction data for this preparation are limited. Androgen-class interactions with anticoagulants, glucose-lowering medicines and other hormones remain relevant considerations. A clinician should review all medicines and supplements; combining agents does not reliably prevent adverse effects.
Pregnancy and Lactation
Avoid during pregnancy because androgen exposure can affect fetal sexual development. Breastfeeding requires specialist advice. Suppression of gonadotropins can reduce sperm production and fertility; recovery is variable.
Side Effects and Adverse Reactions
Possible androgen-class effects include acne, hair changes, altered libido, fluid retention, mood effects, menstrual disturbance and impaired fertility. Injection-site pain or infection may occur. Reliable ingredient-specific human frequencies are not established, and class risks should not be mistaken for a complete adverse-event profile.
Overdose Protocol
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Scientific & Technical Data
Pharmacodynamics
Boldenone Undecylenate is an ester of boldenone. Ester cleavage releases the parent androgen, which acts at androgen receptors. Chemical similarity to other anabolic steroids does not establish equivalent clinical effects or safety.
Pharmacokinetics
The ester and formulation influence release of boldenone from an injection depot. Metabolism and excretion of the parent compound follow release. Human pharmacokinetic data are insufficient to assign a dependable dosing interval or half-life to this catalogue preparation.
Storage and Handling
Keep the finished injectable preparation in its original container and outer packaging, protected from light and extremes of temperature. Use only documented temperature and expiry conditions for that formulation. Do not assume that refrigeration, freezing or warming is appropriate. A pharmacist should assess any temperature excursion or visible change. Keep injectable medicines in their original packaging, protected from light and excessive heat and out of children's reach. Follow the finished medicine's temperature limits and expiry date. Check the container and solution before use. A vial's size does not establish whether it can be reused: follow its single-dose or multidose instructions and the specified discard time after opening. Dispose of needles in a sharps container.
Browse more